AU5160193A - Arsenic medicaments for the treatment of the chronic asthenia syndrome - Google Patents

Arsenic medicaments for the treatment of the chronic asthenia syndrome

Info

Publication number
AU5160193A
AU5160193A AU51601/93A AU5160193A AU5160193A AU 5160193 A AU5160193 A AU 5160193A AU 51601/93 A AU51601/93 A AU 51601/93A AU 5160193 A AU5160193 A AU 5160193A AU 5160193 A AU5160193 A AU 5160193A
Authority
AU
Australia
Prior art keywords
medicaments
arsenic
treatment
chronic
asthenia syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51601/93A
Other languages
English (en)
Inventor
Anna Santamaria
Walter Tarello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5160193A publication Critical patent/AU5160193A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/285Arsenic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/36Arsenic; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU51601/93A 1993-03-17 1993-09-08 Arsenic medicaments for the treatment of the chronic asthenia syndrome Abandoned AU5160193A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT93TO000179A IT1280014B1 (it) 1993-03-17 1993-03-17 Farmaci attivi contro l'agente eziologico della sindrome da astenia cronica
ITTO93A0179 1993-03-17
PCT/IT1993/000093 WO1994021249A1 (en) 1993-03-17 1993-09-08 Arsenic medicaments for the treatment of the chronic asthenia syndrome

Publications (1)

Publication Number Publication Date
AU5160193A true AU5160193A (en) 1994-10-11

Family

ID=11411264

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51601/93A Abandoned AU5160193A (en) 1993-03-17 1993-09-08 Arsenic medicaments for the treatment of the chronic asthenia syndrome

Country Status (3)

Country Link
AU (1) AU5160193A (it)
IT (1) IT1280014B1 (it)
WO (1) WO1994021249A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1295067B1 (it) * 1997-09-25 1999-04-27 Walter Tarello Uso di arsenico per preparare un medicamento per il trattamento della sindrome premestruale
FR2838965B1 (fr) 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
US8394422B2 (en) 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans

Also Published As

Publication number Publication date
ITTO930179A0 (it) 1993-03-17
IT1280014B1 (it) 1997-12-23
ITTO930179A1 (it) 1994-09-18
WO1994021249A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
AU7472594A (en) Extracorporeal affinity adsorption devices
AU6623894A (en) Therapeutic compounds
AU7846694A (en) Adjustable treatment chamber catheter
AU4481193A (en) Glare elimination device
AU4285596A (en) Sudden infant death syndrome prevention apparatus
AU7567394A (en) Treatment chamber catheter
AU7637694A (en) Controlled multi-pharmaceutical inhaler
AU3888793A (en) Novel medicament
AU7961094A (en) Picosulphate dosage form
EP0632022A3 (en) Process for the preparation of amino-substituted thioethers.
AU3045292A (en) Active oxygen scavenger
AU7973994A (en) Combination therapy for hiv infection
AU2986392A (en) Medicaments for treating inflammatory conditions or for analgesia
AU6092794A (en) Oxime-substituted therapeutic compounds
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU4757093A (en) Antinephrotic syndrome agent
AU3328693A (en) Treatment of fungal infections
AU3899893A (en) Compositions for the treatment of acute or chronic inflammation
AU1480497A (en) Cancer treatment
AU3542993A (en) Pharmaceutical compounds
EP0584247A4 (en) Compositons for the treatment of chronic fatigue syndrome
AU2649092A (en) Desulphurisation treatment
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU5160193A (en) Arsenic medicaments for the treatment of the chronic asthenia syndrome
AU5627796A (en) Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury